References - Signal Processing in MRS with Biomedical Applications - page 428

[326] Taylor, K.L., Shelby, R., Gelmann, E., and McGuire, C., Quality of
life and trial adherence among participants in the prostate, lung,
colorectal, and ovarian cancer screening trial, J. Natl. Cancer Inst.,
96, 1083 - 1094, 2004.
[327] McGovern, P.M., Gross, C.R., Krueger, R.A., Engelhard, D.A.,
Cordes, J.E., and Church, T.R., Falsepositive cancer screens and
healthrelated quality of life, Cancer Nurs., 27, 347 - 352, 2004.
[328] U.S. Preventive Services Task Force, Screening for ovarian cancer:
recommendation statement, Ann. Fam. Med., 2, 260 - 262, 2004.
[329] Imaoka, I., Wada, A., Kaji, Y., Hayashi, T., Hayashi, M., Matsuo, M.,
and Sugimura, K., Developing an MR imaging strategy for diagnosis
of ovarian masses, Radiographics, 26, 1431 - 1448, 2006.
[330] Spencer, J.A., A multidisciplinary approach to ovarian cancer at
diagnosis, Br. J. Radiol., 78 (Suppl.), 94 - 102, 2005.
[331] Kinkel, K., Lu, Y., Mehdizade, A., Pelte, MF., and Hricak, H.,
Indeterminate ovarian mass at US: Incremental value of second
imaging test for characterization - Metaanalysis and Bayesian
analysis, Radiology, 236, 85 - 94, 2005.
[332] Harlap, S., Olson, S.H., Barakat, R.R., Caputo, T.A., Forment, S.,
Jacobs, A.J., Nakraseive, C., and Xue, X., Diagnostic Xrays and risk
of epithelial ovarian carcinoma in Jews, Ann. Epidemiol., 12, 426 -
434, 2002.
[333] Hill, D.A., PrestonMartin, S., Ross, R.K., and Bernstein, L., Medical
radiation, family history of cancer and benign breast disease in
relation to breast cancer risk in young women, Cancer Causes Control,
13, 711 - 718, 2002.
[334] Booth, S.J., Pickles, M.D., and Turnbull, L.W., In vivo magnetic
resonance spectroscopy of gynaecological tumors at 3.0 tesla, Br. J.
Obstet. Gynaecol., 116, 300 - 303, 2009.
[335] Cho, S.W., Cho, S.G., Lee, J.H., Kim, H.J., Lim, M.H., Kim, J.H.,
and Suh, C.H., In vivo proton magnetic resonance spectroscopy in
adnexal lesions, Korean J. Radiol., 3, 105 - 112, 2002.
[336] Hascalik, S., Celik, O., and Erdem, G., Magnetic resonance spectral
analysis of ovarian teratomas, Int. J. Gynecol. Obstet., 90, 152 - 152,
2005.
[337] Hascalik, S., Celik, O., Sarak, K., Meydanli, M.M., Alkan, A., and
Mizrak, B., Metabolic changes in pelvic lesions: findings at proton MR
spectroscopic imaging, Gynecol. Obstet. Invest., 60, 121 - 127, 2005.